Aspen Aerogels 10-Q: Q3 Revenue $85.2M, Net Loss $10.4M, $146M Cash
ASPN has more than doubled off its 52-week low of $2.3 on elevated volume (4.1× avg).
Summary
Aspen Aerogels' Q3 10-Q confirms the $85.2M revenue beat and $10.4M net loss, with $146.0M cash and a newly disclosed CEO 10b5-1 plan covering up to 1.25M shares.
Key Events · Earnings and Guidance · ASPN
-
Q3 Revenue $85.2M, Net Loss $10.4M
Revenue rose 17% to $85.2M from $73.0M; net loss widened to $10.4M ($0.13 per share) from $6.3M, and Adjusted EBITDA was $19.8M.
-
Thermal Barrier Slides, Energy Industrial Jumps
Thermal Barrier revenue fell 7% to $45.3M while Energy Industrial rose 64% to $39.9M; gross margin compressed to 24% from 28% on East Providence incident costs.
-
Liquidity: $146.0M Cash, $22.2M Revolver
Cash and equivalents were $146.0M at September 30, 2026; the term loan was paid down to $73.0M from $92.5M, and $22.2M remained available under the Revolving Facility.
-
CEO 10b5-1 Plan for 1.25M Shares
CEO Donald R. Young adopted a Rule 10b5-1 plan on August 12, 2026 covering up to 1,251,949 shares through December 31, 2027 — a pre-scheduled selling overhang, not an executed sale.
Analysis · ASPN · Trade & Services
The 10-Q confirms the Q3 beat already reported in this morning's 8-K and adds the full financials. Revenue rose 17% to $85.2M on a 64% jump in Energy Industrial, but Thermal Barrier fell 7% and gross margin slipped to 24% from 28% as East Providence incident costs hit cost of revenue. The balance sheet is the reassuring part: $146.0M of cash plus $22.2M of revolver availability, with the term loan paid down to $73.0M. The new disclosure is a CEO 10b5-1 plan adopted August 12 covering up to 1,251,949 shares through 2027 — a pre-scheduled selling overhang, not a sale itself.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASPN was trading at $5.16 on NYSE in the Trade & Services sector, with a market capitalization of approximately $428.2M. The 52-week trading range was $2.30 to $8.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.